Discussion Q & A ESMO 2019 Press conference Oavrial & Lung cancer

Discussion Q & A ESMO 2019 Press conference Oavrial & Lung cancerПодробнее

ESMO 2019 Daily Reporter - Editor's Picks: Lung cancerПодробнее

Expert report on neoadjuvant immune checkpoint inhibitors for NSCLCПодробнее

ESMO 2019: Dr. Spigel Highlights Progress in Lung CancerПодробнее

John Strickler: ESMO 2019 HighlightsПодробнее

OncLive News Network On Location: ESMO 2019 Day 1Подробнее

OncLive News Network On Location: ESMO 2019 Day 3Подробнее

ESMO 2020 Expert Video Report on long term ICI outcomes in lung cancerПодробнее

WCLC 2019 Press Conference - September 08, 2019 - IASLCПодробнее

Experts Highlight Anticipated Research to Be Revealed at ESMO 2019Подробнее

Researcher comment: Take-home messages from the CheckMate 227 trial | Solange PetersПодробнее

Supportive care in cancer: more is neededПодробнее

Expert highlights: Lung and thoracic cancers at ESMO 2019 | Ross CamidgeПодробнее

ESMO Congress 2019 Daily Reporter - Editor's Picks: Prostate cancerПодробнее

ESMO 2019 Daily Reporter - Editor's Picks: Ovarian cancerПодробнее

ESMO Congress 2019 Daily Reporter - Editor's Picks: Gastrointestinal cancerПодробнее

Highlights from ESMO 2019Подробнее

WCLC 2019 Press Conference - Monday September 9, 2019Подробнее

A need for continued research with immunotherapy in small cell lung cancer: 2022 ESMO FloridaПодробнее

Comment: Nivolumab plus ipilimumab combination for advanced NSCLCПодробнее